Aging, Cellular Senescence, and Cancer

In the paper

“the effects of the senescent fibroblasts were due primarily to their secretion of matrix metalloproteinases (MMPs), which are prominent SASP components (32, 94).”

What the sources say

• Disputed

  In “SASPs Induce Epithelial–Mesenchyme Transitions and Invasiveness” (page unavailable), the paper reports that senescent fibroblast secretions promoted invasion, but identifies IL-6 and IL-8—not MMPs—as the SASP factors contributing substantially to that effect. Our copy does not identify MMPs as prominent SASP components or as the primary cause of these effects. (LLM, conf=0.82)

  Checked by a reasoning model — may be wrong.

  cites [32] sourceExperimental — accuracy not yet measured
• Partly supported

  The Results section, “Members of MMP and Other Gene Clusters Comprise the Conserved SASP” (page not provided), identifies secreted MMPs as SASP components. The paper does not show that MMPs were primarily responsible for the disruptive effects in the cited cultures; its Discussion instead attributes much of the growth-stimulatory activity to CXCL-1. (LLM, conf=0.86)

  cites [94] sourceExperimental — accuracy not yet measured

In the paper

“Finally, the SASP also includes proteins that can help senescent cells evade immune recognition and clearance (92, 93).”

What the sources say

• Partly supported

  In “The Senescence-Associated Secretory Phenotype Affects Leukocyte Infiltration and Tumor Immunology” (page unavailable), the paper says molecules overexpressed by senescent fibroblasts can lead to an inadequate immune response near those cells. It does not say that these proteins help senescent cells themselves evade immune recognition or clearance; the discussion concerns immune responses in the tumor environment. (LLM, conf=0.85)

  cites [92] sourceExperimental — accuracy not yet measured
• Disputed

  The “Multiple roles of the SASP” section says the SASP might signal the immune system to clear senescent cells. It also describes SASP-associated cytokines and enzymes promoting clearance in mouse models. The cited paper thus makes the contrary point, rather than identifying proteins that help senescent cells evade recognition or clearance. Page numbers were not available in our copy. (LLM, conf=0.84)

  Checked by a reasoning model — may be wrong.

  cites [93] sourceExperimental — accuracy not yet measured

In the paper

“This finding may be complicated by the fact that the proliferative arrest of mouse cells cultured in ambient oxygen concentrations (approximately 20%), which is substantially higher than the oxygen concentrations to which cells are exposed in vivo, has only some features of the senescence response that is induced under more physiological oxygen concentrations (38, 94).”

What the sources say

• Disputed

  The paper reports that mouse embryonic fibroblasts arrested and showed a senescent morphology in 20% oxygen. But in its discussion of growth at physiological 3% oxygen (Fig. 2a; page unavailable), it says the cells grew with little evidence of replicative senescence, rather than undergoing the contrasting senescence response described in the claim. It notes an exception for DNA-repair-deficient Balb/c cells, whose eventual senescence at 3% oxygen had a phenotype similar to that of cells grown at 20%. (LLM, conf=0.86)

  Checked by a reasoning model — may be wrong.

  cites [38] sourceExperimental — accuracy not yet measured
• Supported

  The Discussion (page not provided) says mouse cells arrested in 20% oxygen show some senescence features, including growth arrest and SA-βGal activity, but differ from mouse cells made senescent in physiological oxygen. The Results (page not provided) identify 20% oxygen as atmospheric culture conditions and 3% as physiological oxygen. (LLM, conf=0.94)

  cites [94] source

In the paper

“The permanence of the senescence growth arrest enforces the idea that the senescence response evolved at least in part to suppress the development of cancer (9).”

What the sources say

• Supported

  The Introduction describes senescence as an irreversible loss of proliferative capacity and places it among cellular mechanisms of tumor suppression that evolved to protect against cancer. The “Blocking Tumor Growth by Senescence” section reports experiments examining that protective role. Page numbers are not available in our copy. (LLM, conf=0.90)

  cites [9] source

In the paper

“However, molecular biological manipulations, for example, the sequential inactivation of certain tumor suppressor genes, can cause senescent cells to proliferate (10).”

What the sources say

• Supported

  The Results report that WI-38 cells with p16 suppressed before senescence resumed proliferation after subsequent p53 inactivation; more than 70% proliferated. This supports the cited example of sequential molecular manipulations, though the result depends on when p16 is suppressed. (LLM, conf=0.90)

  cites [10] source

In the paper

“Many types of cytotoxic chemotherapies are severe DNA-damaging agents that can induce senescence in both tumor cells and surrounding normal cells (31–34).”

What the sources say

• Partly supported

  The Results and Discussion (page not available) show that doxorubicin, a DNA-damaging anticancer drug, induced senescence in surviving colon carcinoma cells. The introduction (page not available) also says DNA damage can trigger senescence in normal cells and that various anticancer agents can induce senescence-like arrest in tumor cells. It does not establish that cytotoxic chemotherapies induce senescence in surrounding normal cells. (LLM, conf=0.86)

  cites [31] sourceExperimental — accuracy not yet measured
• Partly supported

  In “Chemotherapy-Induced SASPs Occur In Vivo,” the paper reports that the DNA-damaging chemotherapy mitoxantrone induced senescence in epithelial cell lines and normal fibroblasts in culture, and examines treated tumor cells in vivo. It does not establish that many types of chemotherapy induce senescence in normal cells surrounding tumors. (LLM, conf=0.84)

  cites [32] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [33] source
• Partly supported

  The Introduction (page not supplied) says most conventional agents damage cellular components, often DNA, and that drug-induced damage can initiate senescence. The Discussion reports chemotherapy-induced senescence in a murine lymphoma model. Our copy does not establish that these agents cause severe DNA damage or induce senescence in surrounding normal cells. (LLM, conf=0.86)

  cites [34] sourceExperimental — accuracy not yet measured

In the paper

“Nevertheless, there is substantial overlap among SASPs; proinflammatory cytokines are the most highly conserved feature, cutting across many different cell types and senescence-inducing stimuli (33, 42, 96, 99, 100, 112–114).”

What the sources say

• ?Not checked — no full text of the sourcecites [33] source
• Partly supported

  The passages labeled Abstract report IL-6 and IL-8 secretion in several fibroblast models and under multiple DNA-damaging conditions. They do not compare SASPs to establish that proinflammatory cytokines are their most highly conserved feature; the paper also reports that p16-induced senescence without DNA damage did not initiate a cytokine response. Page numbers are unavailable in our copy. (LLM, conf=0.87)

  cites [42] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [96] source
• Partly supported

  The Results report proinflammatory cytokines among factors secreted during oncogene-induced senescence, and the Discussion describes CXCR2-binding chemokines as upregulated during both replicative and oncogene-induced senescence. The paper does not establish substantial overlap among SASPs across many cell types or show that proinflammatory cytokines are their most highly conserved feature. (LLM, conf=0.84)

  cites [99] sourceExperimental — accuracy not yet measured
• Partly supported

  The Results report that IL-6, IL-1α, IL-1β, and IL-8 were upregulated during oncogene-induced senescence in human fibroblasts and melanocytes. The Discussion also identifies cytokines and chemokines as prominent in that setting. The paper does not establish substantial overlap among SASPs across many senescence-inducing stimuli or show that proinflammatory cytokines are their most highly conserved feature. (LLM, conf=0.86)

  cites [100] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [112] source
• ?Not checked — no full text of the sourcecites [113] source
• ?Not checked — no full text of the sourcecites [114] source

In the paper

“The SASP is primarily a property of cells that senesce owing to, or accompanied by, genomic damage or epigenomic perturbation.”

What the sources say

• Partly supported

  The discussion (p. 7) says chronic DNA-damage signaling is required for a SASP and concludes that the SASP is a consequence of severe DNA damage rather than growth arrest alone. This supports the genomic-damage part of the claim, but the passages do not address epigenomic perturbation as a cause of the SASP. (LLM, conf=0.85)

  cites [115] sourceExperimental — accuracy not yet measured
• Partly supported

  The Results (Figure 1D) show that DNA damage sufficient to cause senescence induced a SASP, while a lower radiation dose did not. The Discussion likewise describes the SASP as a response to severe or irreparable damage. These passages support the genomic-damage part of the claim, but our copy does not establish epigenomic perturbation as another basis for the SASP. (LLM, conf=0.87)

  cites [32] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [33] source
• Partly supported

  In the supplied copy’s Abstract (page not specified), persistent DNA damage correlates with secretion of inflammatory SASP factors, while p16-induced senescence without DNA damage does not initiate that cytokine response. The paper says DNA-damage signalling drives only a subset of SASP factors; it does not establish the claim for the SASP as a whole or address epigenomic perturbation. (LLM, conf=0.86)

  cites [42] sourceExperimental — accuracy not yet measured
• Partly supported

  The Introduction and Results link SASP activation to DNA-damage signaling and show that HDAC inhibition can induce SASP factors without detectable DNA breaks. But the Introduction and Discussion also state that cells unable to senesce can express SASP factors, so the paper does not establish that the SASP is primarily a property of cells that senesce under those conditions. Page numbers are unavailable in our copy. (LLM, conf=0.85)

  cites [67] sourceExperimental — accuracy not yet measured
• Partly supported

  The Results section, “Effect of O2 on DNA Damage and Genomic Instability” (page not available), reports that the SASP correlates with persistent DNA-damage foci in mouse cells, as in human cells. The paper does not establish epigenomic perturbation as a basis for the SASP, and its findings in the cells studied do not establish the claim’s broader “primarily a property” characterization. (LLM, conf=0.86)

  cites [94] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [96] source
• Partly supported

  The Discussion (page unavailable) reports increased secretion of CXCR2-binding chemokines during replicative and especially oncogene-induced senescence, and says the DNA-damage response is central to both. It does not establish that the SASP is primarily limited to cells with genomic damage, or link it to epigenomic perturbation. (LLM, conf=0.82)

  cites [99] sourceExperimental — accuracy not yet measured
• Partly supported

  The paper’s Summary links oncogene-induced senescence to an inflammatory transcriptome and secretion of IL-6. The Introduction discusses DNA-damage signaling in oncogene-induced senescence, and the passage headed “IL-6 Depletion Correlates with Reduced Formation of SAHF” reports chromatin changes. These passages do not establish that the SASP is primarily a property of cells senescing with genomic damage or epigenomic perturbation across senescence types. (LLM, conf=0.82)

  cites [100] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [112] source

In the paper

“Chronic inflammation, of course, is a cause of—or an important contributor to—virtually every major age-related disease, both degenerative and hyperplastic (109–111).”

What the sources say

• Partly supported

  The Introduction calls chronic inflammation a major underlying condition of many age-related diseases, including degenerative conditions and cancer. The Conclusion likewise describes it as a primary factor underlying numerous age-related diseases. Neither passage supports the stronger claim that it contributes to virtually every major age-related disease. (LLM, conf=0.86)

  cites [109] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [110] source
• Partly supported

  The Introduction and Conclusions and Prospective sections (page unavailable) describe chronic inflammation as a contributor to cancer risk and tumor development. They do not support the broader claim about virtually every major age-related disease, including degenerative diseases. (LLM, conf=0.87)

  cites [111] sourceExperimental — accuracy not yet measured

In the paper

“many SASP components directly or indirectly promote inflammation (59, 92, 93, 107, 108).”

What the sources say

• ?Not checked — no full text of the sourcecites [59] source
• Supported

  In the section on soluble signaling factors, the paper identifies several SASP components as inflammatory cytokines, including IL-6 and IL-1. The sections on leukocyte infiltration and cell differentiation describe SASP factors acting on neighboring cells and recruiting inflammatory and immune cells, supporting both direct and indirect effects. Page numbers were not available in our copy. (LLM, conf=0.91)

  cites [92] sourceExperimental — accuracy not yet measured
• Supported

  The section “Senescent cells as a source of chronic inflammation” identifies numerous SASP proteins known to stimulate inflammation. “Chronic inflammation might propel basic aging processes” also describes an indirect route: senescent-cell cytokines attract and activate innate immune cells. (LLM, conf=0.93)

  cites [93] source
• Supported

  The ‘Secretory phenotype of senescent cells’ section describes the SASP as having pro-inflammatory effects and identifies inflammatory cytokines among its components. The ‘Regulation of the inflammatory component of the SASP’ section describes an indirect route: IL-1α promotes expression of IL-6 and IL-8. (LLM, conf=0.91)

  cites [107] sourceExperimental — accuracy not yet measured
• Supported

  The “Cellular senescence” section describes the senescent secretory phenotype as including inflammatory cytokines, ECM-modifying proteases, and reactive oxygen species. It also explains that substances released by senescent cells attract and activate immune cells, supporting both direct and indirect contributions to inflammation. (LLM, conf=0.91)

  cites [108] sourceExperimental — accuracy not yet measured

In the paper

“Many cells undergo senescence in response to severely damaged DNA, regardless of the genomic location (27) (Figure 1).”

What the sources say

• Supported

  The Results section reports that senescent mammalian cell populations had similar total numbers of DNA-damage foci despite widely differing locations on chromosome ends and arms. It proposes that the number of lesions, rather than their location, is the important determinant of senescence; the Discussion describes a threshold of accumulated damage signals. (LLM, conf=0.88)

  cites [27] source

In the paper

“Other DNA lesions—such as those caused by oxidative stress—may also drive cells into senescence (35–38).”

What the sources say

• Partly supported

  The paper’s opening summary (p. 1) identifies oxidative stress as a senescence-inducing condition, and the Discussion (p. 10) describes a pathway by which reactive oxygen species lead to senescence. It does not establish that DNA lesions caused by oxidative stress drive that process; it describes a p38 MAPK–lamin B1 pathway instead. (LLM, conf=0.85)

  cites [35] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [36] source
• Supported

  The Introduction (page unavailable) identifies DNA lesions as a form of ROS-induced damage and says ROS play a critical role in cellular senescence. The Results section on oxidative stress–induced premature senescence (page unavailable) also reports that oxidative stress can induce senescence, supporting the citing sentence’s hedged claim. (LLM, conf=0.86)

  cites [37] source
• Supported

  The Abstract (page not provided) reports that mouse fibroblasts in 20% oxygen accumulated more oxidative DNA lesions than those in 3% oxygen. It also says that low oxygen delayed their senescence, implicating DNA damage in replicative arrest. Together, these passages support the hedged claim that oxidative-stress-related DNA lesions may drive senescence. (LLM, conf=0.90)

  cites [38] source

In the paper

“The secretion of these and similar proteins by senescent cells is predicted to cause chronic inflammation, at least locally and possibly systemically (91–93, 107).”

What the sources say

• Supported

  Section 7 predicts that the chronic presence of senescent cells secreting biologically active proteins alters the local tissue milieu. Section 10 hypothesizes that their pro-inflammatory secretions may also have systemic effects. The citing sentence preserves that uncertainty by saying the effects are 'predicted' and 'possibly' systemic. (LLM, conf=0.92)

  cites [91] Campisi J, 2011, Semin. Cancer Biol. source
• Partly supported

  The sections on soluble signaling factors and leukocyte recruitment describe senescent cells releasing proinflammatory proteins that affect nearby cells and may sustain local immune-cell recruitment. The passages do not address whether this secretion causes systemic inflammation, so the systemic part of the prediction is not supported by our copy. Page numbers were not available. (LLM, conf=0.82)

  cites [92] sourceExperimental — accuracy not yet measured
• Supported

  The section ‘Senescent cells as a source of chronic inflammation’ identifies inflammatory proteins secreted by senescent cells and says they can alter their local microenvironment. The Concluding remarks predict that senescent cells could seed a more systemic chronic inflammatory response. Page numbers are not supplied in our copy. (LLM, conf=0.92)

  cites [93] source
• Supported

  The ‘Secretory phenotype of senescent cells’ section describes the SASP as a pro-inflammatory stimulus with local effects on nearby cells. The Conclusions say senescent cells could also seed a systemic chronic inflammatory response over time, matching the claim’s qualified prediction. (LLM, conf=0.91)

  cites [107] sourceExperimental — accuracy not yet measured

In the paper

“Of particular importance, these DDR proteins stimulate the SASP only after persistent DDR signaling has been established.”

What the sources say

• Partly supported

  In the Discussion, the paper says preliminary data suggest that some DDR components help establish and maintain the SASP. Results associated with Figure 1D show that a robust SASP develops 4–7 days after senescence-causing irradiation, rather than immediately after DNA damage. The paper does not establish that DDR proteins stimulate the SASP only after persistent DDR signaling has been established. (LLM, conf=0.85)

  cites [32] sourceExperimental — accuracy not yet measured
• Partly supported

  The paper’s discussion of its model (page unavailable) says persistent DDR signaling initiates the cytokine response after several days through ATM, NBS1 and CHK2. But its analysis of SASP factors says DDR signaling regulates only a subset, including IL-6 and IL-8, not the SASP as a whole. (LLM, conf=0.85)

  cites [42] sourceExperimental — accuracy not yet measured

In the paper

“As a final example, senescent cells were seen with increased frequency in normal and premature aging skin (78, 82, 84, 121).”

What the sources say

• ?Not checked — no full text of the sourcecites [78] source
• ?Not checked — no full text of the sourcecites [82] source
• ?Not checked — no full text of the sourcecites [84] source
• Supported

  The Results section on aged mouse skin (page unavailable) reports that SA-βgal-positive skin sections increased from 17% in young mice to 78% in old mice. The Results section on Sod2 deficiency (page unavailable) also reports senescence-associated staining in all Sod2−/− mice examined, versus one of eight age-matched wild-type mice, supporting the premature-aging-skin example. (LLM, conf=0.91)

  cites [121] source

In the paper

“In three-dimensional cultures that model the functional and morphological differentiation of breast epithelial cells, for example, the presence of senescent fibroblasts disrupted alveolar and branching morphogenesis, as well as milk protein production (118, 119);”

What the sources say

• ?Not checked — no full text of the sourcecites [118] source
• Partly supported

  The Results report that, in three-dimensional MCF-10A cocultures, senescence-like fibroblasts disrupted branching ductal morphogenesis. They do not report disrupted milk protein production; the resulting cysts retained polarized epithelial cells and hollow lumens. The paper therefore supports the branching finding, but not the full claim about alveolar differentiation and milk production. (LLM, conf=0.90)

  cites [119] sourceExperimental — accuracy not yet measured

In the paper

“The SASP is also positively regulated by the transcription factors nuclear factor κB (NF-κB) (57, 67, 99) and C/EBP-β (100) (Figure 2).”

What the sources say

• ?Not checked — no full text of the sourcecites [57] source
• Partly supported

  The Discussion states that NF-κB and C/EBPβ are required for expression of some SASP factors, supporting their positive regulatory roles. But the Results show that NF-κB is required for IL6 and IL8 upregulation, not OPN upregulation, so the unqualified statement overgeneralizes their regulation of the SASP. (LLM, conf=0.84)

  cites [67] sourceExperimental — accuracy not yet measured
• Supported

  Citation (100) is attached to the C/EBP-β part of the sentence. The Results report that depleting C/EBP-β reduced induction of several secreted CXCR2 ligands during oncogene-induced senescence; the Discussion explicitly implicates C/EBP-β in controlling the associated secretory program. The supplied passages do not give page numbers. (LLM, conf=0.91)

  cites [99] source
• Supported

  Citation (100) is attached to the C/EBP-β part of the sentence, not the NF-κB part. In the section headed “C/EBPβ Is a Critical Regulator of IL-6 in OIS” (page unavailable), the paper reports that C/EBPβ regulates inflammatory genes activated during senescence; it also reports that depleting C/EBPβ sharply reduces IL-6 and IL-8 expression. (LLM, conf=0.92)

  cites [100] source

In the paper

“In most cases, senescent cells have been shown or hypothesized to drive degenerative changes largely through secreted proteins—that is, through the SASP (91).”

What the sources say

• Supported

  Section 8 describes demonstrated tissue disruption mediated largely by secreted MMPs and implicates or proposes SASP effects in a wide variety of age-related pathologies. Its caution that a causal role in age-related degeneration remains speculative is consistent with the claim’s distinction between what has been shown and what has been hypothesized. Page numbers were not available in our copy. (LLM, conf=0.88)

  cites [91] Campisi J, 2011, Semin. Cancer Biol. source

In the paper

“Thus, normal cells that senesce owing simply to the ectopic overexpression of p21 or p16INK4a do not express a SASP, despite undergoing a senescence growth arrest and displaying several other characteristics of senescent cells (115).”

What the sources say

• Supported

  The Results (p. 3) state that fibroblasts made senescent by ectopic p21 expression arrested growth, enlarged, and expressed SAβ-gal, but did not develop a SASP. The same passage concludes that high levels of either p21 or p16 induce these senescence hallmarks without inducing a SASP. (LLM, conf=0.95)

  cites [115] source

In the paper

“In contrast, cells that senesce owing to DNA damage, dysfunctional telomeres, epigenomic disruption, mitogenic signals, oxidative stress, and other senescence-inducing stimuli develop a SASP of varying qualities and robustness (32, 33, 42, 67, 94, 96, 99, 100, 112–114).”

What the sources say

• Partly supported

  The Results report that senescence-causing DNA damage induces a SASP, and the discussion reports a more robust SASP with oncogenic RAS. The paper also describes quantitative and qualitative variation among SASPs. Our copy does not establish SASP development specifically after dysfunctional telomeres, epigenomic disruption, or oxidative stress; the cited passages provide no page numbers. (LLM, conf=0.84)

  cites [32] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [33] source
• Partly supported

  The paper reports SASP-associated cytokine secretion after persistent DNA damage, dysfunctional telomeres, and oncogenic RAS expression (sections on replicative senescence and oncogene-induced senescence; page numbers unavailable). It also shows that secretion varies with the stimulus: p16-induced senescence without DNA damage produced little IL-6. Our copy does not establish SASP development after epigenomic disruption or oxidative stress, so it does not support the full list of stimuli. (LLM, conf=0.88)

  cites [42] sourceExperimental — accuracy not yet measured
• Partly supported

  The Introduction links persistent DNA-damage signaling to some SASP factors, and the Results section on HDAC inhibition reports SASP activation after chromatin-modifying treatment. The Introduction also mentions telomere-driven and oncogene-induced senescence, but does not establish that those stimuli, or oxidative stress, produce a SASP. The paper does not establish the claimed variation in SASP quality and robustness across the listed stimuli. Page numbers were not available in our copy. (LLM, conf=0.84)

  cites [67] sourceExperimental — accuracy not yet measured
• Partly supported

  The Results section reports that irradiated mouse cells developed a SASP whose robustness depended on oxygen conditions, supporting the claim that SASPs can vary. But it also reports that mouse cells senescing under oxidative culture conditions did not develop a SASP. The paper does not establish SASP development for every listed stimulus, including epigenomic disruption and mitogenic signals. (LLM, conf=0.88)

  cites [94] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [96] source
• Partly supported

  The Introduction identifies DNA damage, telomere-related senescence, oncogenic signals, and oxidative stress as senescence triggers. The Discussion says senescent cells produce increased quantities of various secreted proteins, and the Results document secretion during oncogene-induced senescence. These passages do not establish that every listed trigger, including epigenomic disruption, produces a SASP or that its qualities and robustness vary by trigger; page numbers are unavailable in our copy. (LLM, conf=0.84)

  cites [99] sourceExperimental — accuracy not yet measured
• Partly supported

  The Results (page unavailable in our copy) show that oncogenic signaling upregulated inflammatory cytokines in senescent fibroblasts and melanocytes, supporting the mitogenic-signaling part of the claim. The paper does not establish that senescence caused by the other listed stimuli produces a SASP, or compare the quality and robustness of SASPs across those stimuli. (LLM, conf=0.88)

  cites [100] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [112] source
• ?Not checked — no full text of the sourcecites [113] source

In the paper

“These nuclear structures contain the activated DDR proteins that ensure the persistent DDR signaling (43) that is needed for both the senescence growth arrest and the SASP (32, 42, 43).”

What the sources say

• Partly supported

  In the discussion of p53 and the SASP (page unavailable), the paper says preliminary, unpublished data suggest that some DDR components help establish and maintain the SASP. It also says p53 imposes senescence growth arrest after genotoxic stress, but does not establish that persistent DDR signaling is necessary for both arrest and the SASP. The nuclear-structure portion of the citing sentence is attached to a different citation. (LLM, conf=0.85)

  cites [32] sourceExperimental — accuracy not yet measured
• Partly supported

  The indexed main text (page not supplied) reports that persistent DNA damage foci contain activated ATM and are associated with sustained DDR signaling; its model links that signaling to senescence growth arrest and inflammatory cytokine secretion. But the paper calls these structures persistent DNA damage foci, rather than specifically establishing the claim for both DNA-SCARS and TIF, and it says DDR signaling regulates only a subset of SASP factors, not the entire SASP. (LLM, conf=0.87)

  cites [42] sourceExperimental — accuracy not yet measured
• Supported

  The Discussion identifies TIF as a type of DNA-SCARS and proposes that DNA-SCARS provide a reservoir for active DDR signaling needed to maintain growth arrest and inflammatory cytokine secretion. The Results support this link: disrupting DNA-SCARS reduced associated activated CHK2 and relaxed both senescence growth arrest and IL-6 secretion. (LLM, conf=0.90)

  cites [43] source

In the paper

“In senescent cells, an early response to senescence-inducing stimuli is increased expression of IL-1α (116, 117).”

What the sources say

• Partly supported

  The Results section on IL-1α signaling reports high levels of membrane-bound IL-1α in senescent cells, and the Discussion links IL-1α to inflammatory signaling. Neither passage establishes that IL-1α expression increases early after senescence-inducing stimuli; the paper’s timing results concern the SASP and miR-146a/b, not IL-1α. Page numbers are unavailable in our copy. (LLM, conf=0.82)

  cites [116] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [117] source

In the paper

“DNA-SCARS and TIF are particularly important for the effects of the DDR on the SASP.”

What the sources say

• Supported

  The Discussion states that DNA-SCARS are functionally important for IL-6 secretion, an important SASP feature, and proposes that they sustain the DDR signaling needed for inflammatory cytokine secretion. It also states that DNA-SCARS include TIF, which occur at dysfunctional telomeres. (LLM, conf=0.91)

  cites [43] source

In the paper

“In contrast to positive regulation by the DDR, p53 negatively regulates or, more accurately, restrains the SASP (32, 42) (Figure 2).”

What the sources say

• Supported

  In the section “Cell-Nonautonomous Tumor-Suppressive Function of p53” (page not provided), the paper states that p53 restrains the SASP: loss of p53 markedly amplifies it. The Results also report that p53 is not required to initiate the SASP, supporting the citing sentence’s more precise wording, “restrains.” (LLM, conf=0.94)

  cites [32] source
• Supported

  In the paper’s p53-inactivation experiments (indexed as Abstract; page unavailable), IL-6 secretion increased after p53 was inactivated in senescent HCA2 cells and after prolonged p53 loss in proliferating cells. Because the paper identifies IL-6 as a principal SASP factor, these findings support the phrasing that p53 restrains the SASP, without implying that it suppresses every SASP component. (LLM, conf=0.87)

  cites [42] source

In the paper

“This study provided the first direct evidence that senescent cells can, at least in a premature aging mouse model, drive degenerative age-related pathology.”

What the sources say

• Supported

  The Abstract says that whether senescent cells causally contribute to age-related dysfunction had been unknown, then reports that clearing them in BubR1 progeroid mice delayed age-related pathology. The main text (Figs. 2–3) reports delayed cataracts, muscle decline and fat loss alongside reduced senescence markers. Together, these support the description of this study as providing first direct evidence in a premature-ageing mouse model. (LLM, conf=0.93)

  cites [128] source

In the paper

“In the case of senescence induced by certain oncogenes, these cytokines help sustain the senescence growth arrest (discussed below) (99, 100) (Figure 2).”

What the sources say

• Partly supported

  The Results report that knocking down IL-8 or neutralizing it with antibodies alleviated oncogene-induced senescence in IMR-90 cells, supporting a role for IL-8 in reinforcing growth arrest. The cited paper does not establish the same role for IL-6; its experiments here concern IL-8 and other CXCR2 ligands, particularly GROα. (LLM, conf=0.88)

  cites [99] sourceExperimental — accuracy not yet measured
• Supported

  The Results report that IL-6 depletion reversed established oncogene-induced senescence, while IL-8 knockdown allowed cells to bypass it. The Discussion describes both cytokines as causally involved in cells’ ability to undergo oncogene-induced senescence. Together, these passages support the claim that they help sustain the growth arrest; no page numbers are available in our copy. (LLM, conf=0.91)

  cites [100] source

In the paper

“Many, but not all, SASP components are positively regulated by the DDR proteins ATM, NBS1 (Nijmegen breakage syndrome 1), and CHK2 (checkpoint kinase 2) (42, 67).”

What the sources say

• Partly supported

  The paper’s passage on SASP factors (section labelled Abstract; page unavailable) reports that ATM depletion reduced 7 of 16 measured factors, while 9 were unchanged. Its passage on NBS1 and CHK2 shows that depleting either suppressed IL-6 secretion, but does not establish that either regulates many SASP components. (LLM, conf=0.88)

  cites [42] sourceExperimental — accuracy not yet measured
• Supported

  The Introduction (page not provided) states that signaling downstream of ATM, including NBS1 and Chk2, controls a subset of SASP factors, including IL6 and IL8. The Results section, “SASP is controlled by distinct regulatory mechanisms” (page not provided), shows that ATM depletion reduces IL6 and IL8 but does not affect OPN, supporting the qualification that not all components are regulated this way. (LLM, conf=0.92)

  cites [67] source

In the paper

“Furthermore, p53 inactivation in cells that do not express p16INK4a, which renders the senescence growth arrest irreversible (10), causes cells to resume proliferation, but the SASP remains active (32, 42).”

What the sources say

• Partly supported

  In the discussion of p53 and the SASP (page not available in our copy), the paper says that cells with low p16INK4a levels resume proliferation after p53 inactivation but do not lose the SASP. It does not say these cells do not express p16INK4a at all; the experimental passage describes reduced or low expression. (LLM, conf=0.87)

  cites [32] sourceExperimental — accuracy not yet measured
• Partly supported

  The passage on p53 inactivation in senescent HCA2 cells (section labeled Abstract; page unavailable) reports that growth arrest reversed while IL-6 secretion persisted and increased. It describes the cells as expressing low levels of p16INK4a, however, not as having no p16INK4a expression. (LLM, conf=0.86)

  cites [42] sourceExperimental — accuracy not yet measured

In the paper

“In normal senescent cells that express a SASP, inactivation of p53—for example, by RNA interference or expression of dominant negative proteins—causes a striking hyperincrease in the secretion of several SASP factors, due primarily to an increase in mRNA abundance (32).”

What the sources say

• Partly supported

  In Results (‘Cell-Nonautonomous Tumor-Suppressive Function of p53’; Fig. 6), the paper reports that p53 inactivation by a suppressor peptide or shRNA markedly increases secretion of a subset of SASP proteins. Results (Fig. 1E–F) and the Discussion say many SASP factors are up-regulated at the mRNA level, but do not establish that increased mRNA abundance is the primary cause of the additional secretion after p53 inactivation. Page numbers are not provided in our copy. (LLM, conf=0.85)

  cites [32] sourceExperimental — accuracy not yet measured

In the paper

“This plasma membrane–associated cytokine binds its plasma membrane–associated receptor (IL1R), which in turn initiates a signaling cascade that ultimately activates NF-κB (116, 117).”

What the sources say

• Supported

  The Results (Figure 5C caption) state that IL-1α interacts with its receptor and activates an IRAK1-dependent pathway leading to NF-κB activation. The same Results section describes IL-1α as membrane-bound in senescent cells. (LLM, conf=0.92)

  cites [116] source
• ?Not checked — no full text of the sourcecites [117] source

In the paper

“NF-κB, in turn, induces the transcription of genes encoding inflammatory mediators such as IL-6 and IL-8 (32, 94, 99, 100).”

What the sources say

• Partly supported

  The SASP-components passage identifies IL-6 and IL-8 as inflammatory cytokines, and the passage on senescent cells reports increased IL-6 and IL-8 protein levels. Neither passage, nor the additional passages retrieved, says that NF-κB induces transcription of their genes. Section labels and page numbers were not supplied for these passages. (LLM, conf=0.82)

  cites [32] sourceExperimental — accuracy not yet measured
• Partly supported

  The Results section on CXCL-1 identifies IL-6 and IL-8 as highly secreted human senescence-associated factors, and the section on mRNA and intracellular protein levels reports increased IL-6 mRNA in senescent mouse cells at 3% oxygen (page numbers unavailable). Neither passage establishes that NF-κB induces transcription of IL-6 or IL-8; searches for NF-κB and NF-kappaB did not locate that mechanism in our copy. (LLM, conf=0.83)

  cites [94] sourceExperimental — accuracy not yet measured
• Partly supported

  The Results (page unavailable) report that depleting the NF-κB component RelA reduced IL-8 production and that RelA bound the IL-8 promoter, suggesting direct regulation. The cited paper does not establish that NF-κB induces IL-6 transcription; its relevant findings concern IL-8 and other CXCR2 ligands. (LLM, conf=0.86)

  cites [99] sourceExperimental — accuracy not yet measured
• Partly supported

  The section “C/EBPβ Is a Critical Regulator of IL-6 in OIS” (page unavailable) identifies IL6 and IL8 as inflammatory genes regulated by C/EBPβ. The “IL-8 Plays a Role in OIS” passage also reports C/EBPβ recruitment to both promoters. Searches for NF-κB and its regulation of IL6 and IL8 found no passage supporting the claim that NF-κB induces their transcription. (LLM, conf=0.82)

  cites [100] sourceExperimental — accuracy not yet measured

In the paper

“In addition, senescent endothelial and smooth muscle cells have been implicated in the genesis or promotion of age-related cardiovascular disease (126, 127).”

What the sources say

• ?Not checked — no full text of the sourcecites [126] source
• Supported

  Section 2.2 (page not supplied) explicitly says that endothelial cell senescence contributes to atherogenesis. The Introduction and Conclusions (pages not supplied) implicate vascular smooth muscle cell senescence in plaque instability, impaired repair, and atherosclerosis. Together these support the hedged claim about both cell types in cardiovascular disease. (LLM, conf=0.93)

  cites [127] source

In the paper

“The idea that senescent cells can drive age-related pathology recently received substantial support from a transgenic mouse model in which senescent cells could be eliminated by administering a drug (128).”

What the sources say

• Supported

  The main text reports that administering AP20187 to INK-ATTAC transgenic mice cleared p16Ink4a-positive senescent cells and delayed age-related dysfunction in a progeroid mouse background (Figs. 2–3; page not provided). The Methods section confirms that the drug was administered by injection. (LLM, conf=0.94)

  cites [128] source

In the paper

“Even more ironic is the finding that senescent cells, particularly those that senesce in response to DNA-damaging radiation or chemotherapeutic agents, secrete factors that can protect neighboring tumor cells from being killed by those same chemotherapeutic agents (133, 134).”

What the sources say

• Partly supported

  The Results section (‘Therapy induces damage responses in tumor microenvironments’; page unavailable) reports that chemotherapy or radiation increased extracellular WNT16B from prostate fibroblasts. ‘Paracrine WNT16B attenuates the effect of cytotoxic therapy’ reports improved tumor-cell survival and reduced apoptosis during mitoxantrone treatment. The Discussion links the damage-response secretome to a senescence phenotype, but the cited experiments do not establish that the protective fibroblasts had themselves become senescent. (LLM, conf=0.83)

  cites [133] sourceExperimental — accuracy not yet measured
• Partly supported

  The Results and Discussion (page not provided) show that endothelial cells exposed to doxorubicin release factors that protect nearby lymphoma cells from chemotherapy. But the protective release occurs before senescence; the Discussion says the later senescence-associated secretory response cannot effectively alter the initial treatment response. The paper therefore does not establish that already-senescent cells provide the protection described. (LLM, conf=0.89)

  cites [134] sourceExperimental — accuracy not yet measured

In the paper

“Likewise, GROα, a potent mitogen that is a SASP component and is induced by oncogenic RAS, promotes the senescence of normal human ovarian fibroblasts (95).”

What the sources say

• Partly supported

  The Results report that Gro-1 treatment induced senescence markers in two normal ovarian stromal fibroblast lines, and the paper states that RAS activates Gro-1. It also describes Gro-1 as a mitogen. Our copy does not identify Gro-1 as a SASP component, so that part of the attributed description is unsupported. (LLM, conf=0.86)

  cites [95] sourceExperimental — accuracy not yet measured

In the paper

“In the cases of IL-6 and IL-8, these SASP components appear to act by instituting a self-sustaining intracellular signaling loop that ultimately activates the NF-κB and C/EBP-β transcription factors (99, 100).”

What the sources say

• Partly supported

  The Results report that IL-8 reinforces senescence and that NF-κB and C/EBPβ regulate IL-8 production. The Discussion suggests CXCR2 ligands may act through intracellular or autocrine receptor activation, but the paper does not establish a self-sustaining loop in which IL-8 activates those transcription factors; the passages also do not address IL-6 in that mechanism. Pages are not available in our copy. (LLM, conf=0.84)

  cites [99] sourceExperimental — accuracy not yet measured
• Partly supported

  In the passage on IL-6 and C/EBPβ (labelled Abstract in our copy; page unavailable), the authors propose a positive feedback loop that sustains C/EBPβ activity. The 'IL-8 Plays a Role in OIS' passage describes IL-8 as dependent on IL-6 and regulated by C/EBPβ, but does not establish that IL-8 drives the loop. The passages do not support the claimed activation of NF-κB or describe the loop as intracellular. (LLM, conf=0.86)

  cites [100] sourceExperimental — accuracy not yet measured

In the paper

“Senescent fibroblasts induce an epithelial-to-mesenchymal transition in premalignant epithelial cells and nonaggressive cancer epithelial cells in part through the secretion of IL-6 and IL-8 (32, 102, 118).”

What the sources say

• Partly supported

  In “SASPs Induce Epithelial–Mesenchyme Transitions and Invasiveness” (page unavailable), the paper reports that senescent fibroblast secretions induced EMT in two nonaggressive breast cancer cell lines. It also reports invasion by premalignant MCF-10A cells and finds that blocking IL-6 and IL-8 reduced invasion, but it does not directly show EMT in the premalignant cells. (LLM, conf=0.84)

  cites [32] sourceExperimental — accuracy not yet measured
• Partly supported

  The sections “Effects of the SASP on Cell Migration and Invasion” and “Effects of the SASP on Epithelial Cell Proliferation and Differentiation” report EMT in nonaggressive breast cancer cells and attribute EMT-like changes in mammary epithelial cells partly to IL-6 and IL-8. For premalignant epithelial cells, the paper describes stimulated growth or progression, not an IL-6/IL-8-mediated EMT. Page numbers are not available in our copy. (LLM, conf=0.86)

  cites [102] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [118] source

In the paper

“One such phenotype is the epithelial-to-mesenchymal transition (102) (Figure 2).”

What the sources say

• Supported

  The section “Importance of the EMT during Development and Cancer” describes EMT as a phenotypic change involved in tumor progression. The paper also notes that EMT occurs normally during development, but supports the citing sentence’s identification of EMT as a phenotype relevant to malignancy. Page numbers were not provided in our copy. (LLM, conf=0.91)

  cites [102] source

In the paper

“In addition, genomic damage—a common cause of cellular senescence—induces expression of the membrane-bound ligands for the major natural killer cell receptor NKG2D (140).”

What the sources say

• Supported

  The Abstract reports that genotoxic stress upregulated mouse and human NKG2D ligands, and the passage describing the experiments specifies that the increase was detected on the cell surface. The parenthetical about senescence is contextual framing; the cited finding is the induction of NKG2D ligands by genomic damage. (LLM, conf=0.90)

  cites [140] source

In the paper

“In contrast, at least some SASP components can be chemosensitizing.”

What the sources say

• Supported

  The Discussion states that disrupting the SASP through NF-κB inhibition promotes chemoresistance in the lymphoma model by impairing treatment-induced senescence and immune clearance. This supports the cautious claim that SASP components can contribute to chemosensitivity in that context. (LLM, conf=0.88)

  cites [135] source

In the paper

“For example, global suppression of the SASP (through NF-κB inhibition) promoted resistance to chemotherapy in a mouse lymphoma model (135).”

What the sources say

• Supported

  The Discussion states that disrupting the SASP through NF-κB inhibition promotes chemoresistance in the lymphoma model. The section “Disruption of NF-κB leads to chemoresistance and reduced survival” reports that p65-suppressed lymphomas responded poorly to chemotherapy in mice. Page numbers were not supplied. (LLM, conf=0.92)

  cites [135] source

In the paper

“Indeed, aging tissues show a steady accumulation of cells that harbor DNA damage foci, similar to the foci that are found in senescent cells (29, 30, 144).”

What the sources say

• ?Not checked — no full text of the sourcecites [29] source
• ?Not checked — no full text of the sourcecites [30] source
• Supported

  The Abstract reports an age-dependent increase in telomere-associated DNA damage foci in mouse gut and liver and describes persistent DNA damage foci in senescent cells. The Results section, “TAF increase with age irrespective of telomere length,” further reports that the percentage of these foci per cell increases linearly with age in both tissues. (LLM, conf=0.91)

  cites [144] source

In the paper

“Among the cells that participate in the clearance of senescent cells are natural killer cells, macrophages, and T cells (131, 135, 139).”

What the sources say

• ?Not checked — no full text of the sourcecites [131] source
• Partly supported

  The NF-κB controls the SASP section reports that natural killer cells target senescent cells, and the figure caption describes their recognition and killing of those cells. The paper does not identify macrophages or T cells as clearing senescent cells; its mention of macrophages concerns apoptotic cells in lymph nodes. Page numbers are unavailable in our copy. (LLM, conf=0.88)

  cites [135] sourceExperimental — accuracy not yet measured
• Partly supported

  The Discussion says natural killer (NK) cells clear senescent activated stellate cells, and the Results show that altering NK-cell activity affects their clearance. The Results also place macrophages near cells with senescence markers and mention T cells as potential participants in NK-influenced killing, but do not establish that macrophages or T cells participate in clearing the senescent cells studied here. The indexed passages provide section labels but no page numbers. (LLM, conf=0.87)

  cites [139] sourceExperimental — accuracy not yet measured

In the paper

“In mouse cells, the SASP factor PAI-1 (plasminogen activator inhibitor 1) reinforces replicative senescence (137).”

What the sources say

• Supported

  The paper reports that PAI-1 knockdown lets mouse embryo fibroblasts bypass replicative senescence, while PAI-1 overexpression induces senescence (Figs. 1 and 4). It also describes PAI-1 as an extracellular-matrix-associated protein upregulated in senescent fibroblasts and proposes it as a secreted gatekeeper of fibroblast proliferation (Abstract). No page numbers are supplied in our copy. (LLM, conf=0.90)

  cites [137] source

In the paper

“There is little doubt that the senescence growth arrest suppresses the development of cancer (8, 48, 136).”

What the sources say

• ?Not checked — no full text of the sourcecites [8] source
• ?Not checked — no full text of the sourcecites [48] source
• Supported

  The Preface describes senescence as a stable block on proliferation and says progression to malignancy requires evading it. The section “Senescence is a tumour suppressive mechanism” reports mouse-model evidence that disabling senescence allows premalignant lesions to progress to cancer, calling the causal link compelling. (LLM, conf=0.92)

  cites [136] source

In the paper

“Senescent cells, presumably by virtue of SASP-derived factors, can stimulate the infiltration of leukocytes (93, 131, 132), which produce reactive toxic moieties that can cause DNA damage.”

What the sources say

• Supported

  The citation is attached to the claim that senescent cells can stimulate immune-cell infiltration through secreted factors. In “Chronic inflammation might propel basic aging processes” (page unavailable), the paper says cytokines produced by senescent cells attract and activate innate immune cells; “Multiple roles of the SASP” also describes an infiltrating immune response following senescence. (LLM, conf=0.90)

  cites [93] source
• ?Not checked — no full text of the sourcecites [131] source
• Supported

  The cited paper reports that p53-reactivated senescent liver tumours upregulated inflammatory cytokines known to attract immune cells, and that neutrophils, macrophages and natural killer cells infiltrated the tumours (passages [1] and [3], labelled Abstract). This supports the leukocyte-infiltration point to which the citation is attached; the later DNA-damage clause is not assessed as a claim attributed to this citation. (LLM, conf=0.88)

  cites [132] source

In the paper

“These chemoprotective SASP factors include WNT16B, IL-6, and TIMP-1 (tissue inhibitor of metalloproteinases-1).”

What the sources say

• Partly supported

  The Results section ('Paracrine WNT16B attenuates the effect of cytotoxic therapy'; page unavailable) shows that WNT16B-containing conditioned medium reduced chemotherapy-induced cytotoxicity. The Discussion (page unavailable) links the damage-response secretory program to SASP and mentions IL-6, but describes IL-6 as reinforcing senescence and immune responses, not as chemoprotective. The copy does not establish TIMP-1 as a chemoprotective SASP factor (searched: TIMP-1, TIMP1, tissue inhibitor of metalloproteinases). (LLM, conf=0.87)

  cites [133] sourceExperimental — accuracy not yet measured
• Partly supported

  The Introduction and Results identify IL-6 and TIMP-1 as factors that protect lymphoma cells from chemotherapy, but our copy does not identify WNT16B as one of them. The Discussion also distinguishes the acute chemoprotective response from the later senescence-associated secretory phenotype (SASP), stating that SASP occurs too late to alter the initial treatment response. No page numbers are available in our copy. (LLM, conf=0.88)

  cites [134] sourceExperimental — accuracy not yet measured

In the paper

“Other SASP factors implicated in stimulating tumor cell growth are amphiregulin and the GROs (94–96), but there are a plethora of other candidates.”

What the sources say

• Partly supported

  The Results section, “CXCL-1 (GRO-α/KC) Is a Major Conserved Factor That Stimulates Epithelial Cell Growth” (page unavailable), identifies GRO-α/KC as a SASP factor that stimulates growth of premalignant and malignant epithelial cells. Our copy does not identify amphiregulin as a growth-stimulating SASP factor; it also directly tests GRO-α/KC rather than establishing the effect for GROs generally. (LLM, conf=0.86)

  cites [94] sourceExperimental — accuracy not yet measured
• Partly supported

  The Results show that Gro-1 promotes ovarian tumor growth and that Gro-1-induced senescent fibroblasts enhance tumor formation. But the paper studies Gro-1 specifically, not the GRO family as a whole, and describes Gro-1 secretion by transformed epithelial cells rather than establishing it as a factor secreted by senescent cells. (LLM, conf=0.84)

  cites [95] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [96] source

In the paper

“Given the proinflammatory nature of the SASP, it is not surprising that senescent cells can attract immune cells, including destructive leukocytes of the innate and adaptive immune systems (131, 132, 135).”

What the sources say

• ?Not checked — no full text of the sourcecites [131] source
• Partly supported

  The Abstract reports that senescent liver tumours produced inflammatory signals that attract immune cells and were infiltrated by neutrophils, macrophages and natural killer cells. It supports attraction and destructive activity by innate immune cells, but not by adaptive immune cells: the main experiments used mice lacking functional B and T cells. (LLM, conf=0.90)

  cites [132] sourceExperimental — accuracy not yet measured
• Partly supported

  The introductory passage (page unavailable) says SASP factors attract immune cells that can eliminate senescent cells. The NF-κB controls the SASP section reports targeting by natural killer cells, and the drug-induced senescence section reports immune-cell infiltration, especially NK cells. Our copy does not establish attraction of destructive leukocytes from both the innate and adaptive immune systems. (LLM, conf=0.85)

  cites [135] sourceExperimental — accuracy not yet measured

In the paper

“In human cells, IL-6, IL-8, and IGFBP7 (insulin-like growth factor–binding protein 7) reinforce the senescence growth arrest caused by the oncogenic forms of RAS and BRAF (99, 100, 114).”

What the sources say

• Partly supported

  The Results report that reducing or neutralizing IL-8 alleviated oncogene-induced senescence in human IMR-90 cells, supporting IL-8’s role in reinforcing the arrest. The paper does not establish the same role for IL-6; its Discussion mentions IGFBP7 and BRAF in connection with another study rather than as a finding of this study. Thus this source supports part, but not all, of the combined claim. (LLM, conf=0.86)

  cites [99] sourceExperimental — accuracy not yet measured
• Partly supported

  The Results ('IL-6 Inhibits Proliferation in the Context of Oncogenic Stress'; page unavailable) report that IL-6 augmented growth arrest under oncogenic stress, including in a BRAF-mutant setting. The section 'IL-8 Plays a Role in OIS' reports that IL-8 knockdown allowed cells to bypass senescence. Our copy does not establish the claimed role for IGFBP7, so it supports only part of the sentence. (LLM, conf=0.88)

  cites [100] sourceExperimental — accuracy not yet measured
• ?Not checked — no full text of the sourcecites [114] source

In the paper

“In addition to stimulating tumor growth in mice, SASP factors can stimulate malignant phenotypes in culture.”

What the sources say

• Supported

  The ‘Effects of the SASP on Cell Migration and Invasion’ section reports that factors secreted by senescent fibroblasts enhanced cancer-cell invasiveness in culture and that conditioned medium stimulated basement-membrane invasion. It explicitly concludes that SASP activity can promote malignant phenotypes in nearby cells. (LLM, conf=0.94)

  cites [102] source

In the paper

“There is a striking, well-documented age-related decline in the adaptive immune system, particularly in the ability to mount functional T cell–mediated responses (141).”

What the sources say

• Supported

  The Introduction states that aging causes a loss of adaptive immune function and describes substantial age-related changes in T-cell numbers and function. It also notes dysregulation of the cell-mediated immune response, supporting the claim’s emphasis on functional T-cell responses. (LLM, conf=0.94)

  cites [141] source

In the paper

“This decline is largely responsible for the heightened susceptibility to infection in the elderly.”

What the sources say

• Supported

  The Abstract identifies increased susceptibility to infectious diseases as a major consequence of immune senescence and says age-related changes in immune function reduce protection against infection. This supports the claim that declining immune function contributes substantially to infection susceptibility in older adults. (LLM, conf=0.89)

  cites [141] source

In the paper

“These results provide a causal explanation for earlier findings showing that the presence of senescent hepatic stellate cells correlates with increased inflammation but reduced fibrosis (148).”

What the sources say

• Partly supported

  The Results and Discussion report that senescent hepatic stellate cells in culture have a more inflammatory, less fibrogenic phenotype. They do not show that the presence of these cells in the liver correlates with increased inflammation and reduced fibrosis; the Discussion describes its comparison of human livers as preliminary gene-expression evidence, not that correlation. (LLM, conf=0.86)

  cites [148] sourceExperimental — accuracy not yet measured

In the paper

“In this case, the senescence response was induced by a signaling cascade that was initiated by the binding of CCN1, a matricellular protein, to its receptor, an integrin, on the surface of the target cells (149).”

What the sources say

• Supported

  The Discussion states that CCN1 induces senescence by binding the cell-adhesion receptors integrin α6β1 and cell-surface HSPGs, then engaging senescence pathways. The Results section on integrin signaling reports that blocking α6β1 binding prevents CCN1-induced senescence. The citing sentence is a supported paraphrase, though it omits the involvement of HSPGs; page numbers were not provided. (LLM, conf=0.92)

  cites [149] source

In the paper

“However, when chronically present, they may promote phenotypes associated with skin aging (121).”

What the sources say

• Supported

  The Discussion says that senescent cells in the aging mouse epidermis may partially explain epidermal thinning, a skin-aging phenotype. It also reports that constitutive Sod2 deficiency produced both epidermal senescence and thinning. The claim’s cautious “may promote” reflects that evidence; the paper does not separately test how long the cells must persist. (LLM, conf=0.88)

  cites [121] source

In the paper

“In the skin, for example, senescent cells clearly promote optimal wound healing (149).”

What the sources say

• Partly supported

  The Results section reports that CCN1-induced senescent fibroblasts restrict excessive collagen deposition in healing mouse skin wounds, supporting a beneficial role. But it also reports that wounds with markedly fewer senescent cells closed somewhat faster, so the paper supports reduced fibrosis rather than an unqualified claim that senescent cells promote optimal wound healing overall. Page numbers are unavailable in our copy. (LLM, conf=0.84)

  cites [149] sourceExperimental — accuracy not yet measured

In the paper

“Recent findings have uncovered an additional beneficial effect of the senescence response and accompanying SASP: the ability to promote optimal repair of damaged tissue (59, 91, 145–147).”

What the sources say

• ?Not checked — no full text of the sourcecites [59] source
• Supported

  Section 6, “Beneficial effects of the SASP,” says the SASP may stimulate tissue repair and describes recent findings in skin wounds and liver damage in which senescent cells appeared to limit fibrosis during repair. This supports the claimed beneficial role, though the paper phrases the mechanism cautiously. (LLM, conf=0.90)

  cites [91] Campisi J, 2011, Semin. Cancer Biol. source
• Supported

  In “Cellular senescence and tissue repair” (page not supplied), the paper describes two mouse studies in which senescence limited fibrosis after tissue damage and says that senescent cells, particularly the SASP, may stimulate repair. Its reference annotation also describes senescent-cell secretions as important for proper tissue repair. (LLM, conf=0.90)

  cites [145] source
• Partly supported

  The section “p53 and PAI-1 Regulate Senescence via Secreted Factors” (p. 4) suggests that secreted factors from senescent fibroblasts may help nearby epithelial cells proliferate and close a wound. But “Conclusions and outlook” (p. 5) says their effect on epithelial cells remains to be investigated. The paper therefore supports a possible role in wound repair, not an established ability of senescence and its accompanying secretions to promote optimal tissue repair. (LLM, conf=0.88)

  cites [146] sourceExperimental — accuracy not yet measured
• Supported

  In “Cellular senescence and tissue repair” (page not provided), the paper describes studies in which senescence and SASP-associated factors helped resolve fibrosis after liver injury and in healing wounds. It concludes that the senescence response may be necessary for resolving normal tissue damage, supporting the cited claim about a beneficial role in repair. (LLM, conf=0.90)

  cites [147] source

In the paper

“In a mouse model of acute liver injury, the injury induced the senescence of hepatic stellate cells, which were eventually cleared by the immune system (principally by natural killer cells) (139).”

What the sources say

• Partly supported

  The Results section reports that senescent activated hepatic stellate cells were cleared from mouse livers, principally through natural killer cell activity. But the Introduction and Experimental Procedures describe repeated CCl4 treatment to induce fibrosis—a model of chronic liver damage, not a model of acute liver injury. Page numbers are unavailable in our copy. (LLM, conf=0.90)

  cites [139] sourceExperimental — accuracy not yet measured

In the paper

“Likewise, in a mouse model of skin wounding, the injury again induced cellular senescence, most likely in resident fibroblasts.”

What the sources say

• Partly supported

  The Results section reports that senescent cells accumulated in healing mouse wounds and identifies them as myofibroblasts; fibroblasts isolated from the wounds also showed senescence. It does not establish that those fibroblasts were resident cells rather than cells of another origin. No page number is available in our copy. (LLM, conf=0.82)

  cites [149] sourceExperimental — accuracy not yet measured

In the paper

“When the injury was performed on mice that were deficient in the p53/p21 and p16INK4a/pRB pathways—that is, mice deficient in undergoing a senescence response—healing was accompanied by a marked increase in fibrosis (139).”

What the sources say

• Partly supported

  The Results section (“Fibrosis progression is restricted by an intact senescence machinery”; page unavailable) reports that mice lacking both p53 and INK4a/ARF had impaired senescence and more than 50% greater fibrotic area than wild-type mice. But the experiment used repeated CCl4 treatment, which the paper describes as chronic liver damage, not acute injury. The Results section on fibrosis reversion also reports more lesions remaining in the double mutants after treatment stopped, rather than an increase arising during healing from an acute injury. (LLM, conf=0.90)

  cites [139] sourceExperimental — accuracy not yet measured

In the paper

“Importantly, wounds in these mice healed with significantly more fibrosis (149).”

What the sources say

• Supported

  The Results section, ‘CCN1-regulated senescence restricts fibrosis in cutaneous wound healing,’ reports significantly higher collagen deposition in Ccn1dm/dm wounds than in wild-type wounds, persisting at least 21 days after wounding. It also reports increased collagen staining and describes an enhanced fibrotic response in the mutant mice. (LLM, conf=0.94)

  cites [149] source

In the paper

“In mice engineered to express a mutant CCN1 protein that is defective in integrin binding and hence in inducing senescence, the wounds were deficient in senescent cells and SASP gene expression.”

What the sources say

• Supported

  The Results (pages not provided) describe knock-in mice expressing CCN1 with disrupted α6β1-integrin/HSPG binding sites and report markedly fewer senescent cells in their wounds. The wound-tissue Results also report lower expression of Mmp2, Mmp3, and Mmp9, while the fibroblast experiments show that the mutant protein could not trigger the SASP/SMS. (LLM, conf=0.89)

  cites [149] source

In the paper

“Regardless, the senescence arrest is stringent.”

In the paper

“Thus, the senescence response may be the result of antagonistically pleiotropic gene action.”

In the paper

“In this regard, cancer is no different from the other diseases of aging, despite very different manifestations.”

In the paper

“That is, natural selection cannot eliminate genes that promote early-life survival but incongruously also promote late-life debility (2), a concept termed antagonistic pleiotropy.”

What the sources say

• ?Not checked — no full text of the sourcecites [2] source

In the paper

“Nonetheless, a surprisingly large number of aging pathologies have been linked, directly or indirectly, to the senescence response.”

In the paper

“It is established and maintained by at least two major tumor suppressor pathways—the p53/p21 and p16INK4a/pRB pathways—and is now recognized as a formidable barrier to malignant tumorigenesis.”

In the paper

“Evolutionary theory holds that aging is a consequence of the declining force of natural selection with age (1).”

What the sources say

• ?Not checked — no full text of the sourcecites [1] Rose MR, 1991 source

In the paper

“The senescence arrest is considered irreversible because no known physiological stimuli can stimulate senescent cells to reenter the cell cycle.”

In the paper

“For most species, aging promotes a host of degenerative pathologies that are characterized by debilitating losses of tissue or cellular function.”

In the paper

“There is mounting evidence that at least one process—a stress response termed cellular senescence—links multiple pathologies of aging, both degenerative and hyperplastic.”

In the paper

“As discussed below, antagonistic pleiotropy is key to understanding many aspects of aging, especially the relationship between aging and cancer.”

What the sources say

• ?Not checked — no full text of the sourcecites [2] source

In the paper

“Consistent with this view, cells undergo senescence in response to a host of potentially oncogenic stimuli or their sequelae.”

In the paper

“Consequently, there are generally few old survivors on which natural selection can act to eliminate alleles or genes that have late-acting deleterious effects.”

What the sources say

• ?Not checked — no full text of the sourcecites [1] Rose MR, 1991 source

In the paper

“Although species vary in their susceptibilities to specific age-related pathologies, collectively, age-related pathologies generally rise with approximately exponential kinetics beginning at approximately the mid-point of the species-specific life span (e.g., 50–60 years of age for humans) (3, 4).”

What the sources say

• ?Not matched

  Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  cites [3] 3. Alliance Aging Res. 2009. The Silver Book. Chronic Disease and Medical Innovation in an Aging Nation. http://www.silverbook.org/
• ?Not matched

  Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  cites [4] 4. Natl. Cent. Health Stat. 2007. Health, United States, 2007. Hayattsville, MD: US Gov. Print. Off. 567 pp.

In the paper

“In contrast to the loss of function that characterizes degenerating cells and tissues, malignant (cancerous) cells must acquire new (albeit aberrant) functions that allow them to develop into a lethal tumor.”

In the paper

“However, recent evidence strengthens the idea that it also drives both degenerative and hyper-plastic pathologies, most likely by promoting chronic inflammation.”

In the paper

“Cancer, like the age-related degenerative diseases, increases in incidence with nearly exponential kinetics beginning at approximately the mid-point of the life span (in species that are susceptible to this disease) (3, 6, 7).”

What the sources say

• ?Not matched

  Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  cites [3] 3. Alliance Aging Res. 2009. The Silver Book. Chronic Disease and Medical Innovation in an Aging Nation. http://www.silverbook.org/
• ?Not checked — no full text of the sourcecites [6] source
• ?Not checked — no full text of the sourcecites [7] source

In the paper

“In organisms with renewable tissues, aging is also marked by an increase in hyperplasias, the most serious of which are cancers.”

In the paper

“This review discusses the idea that, despite seemingly opposite characteristics, the degenerative and hyperplastic pathologies of aging are at least partly linked by a common biological phenomenon: a cellular stress response known as cellular senescence.”

In the paper

“Functional telomeres prevent DNA repair machineries from recognizing chromosome ends as DNA double-strand breaks (DSBs), to which cells rapidly respond and attempt repair.”

In the paper

“Thus, repeated cell division in the absence of telomerase eventually causes one or more telomeres to become critically short and dysfunctional.”

In the paper

“As discussed below, the paracrine activities of senescent cells can be either beneficial or deleterious, depending on the physiological context.”

In the paper

“Telomere shortening does not occur in cells that express telomerase, the reverse transcriptase that can replenish the repetitive telomeric DNA de novo (15, 16).”

What the sources say

• ?Not checked — no full text of the sourcecites [15] source
• ?Not checked — no full text of the sourcecites [16] source

In the paper

“The DDR, in turn, arrests cell division primarily through activities of the p53 tumor suppressor, thereby preventing genomic instability.”

In the paper

“In addition to arrested growth, senescent cells show widespread changes in chromatin organization and gene expression.”

In the paper

“The link between the Hayflick limit and aging was, for many years, conjectural and tenuous—largely on the basis that replicatively senescent cells appeared to be degenerated, although they remained viable and metabolically active.”

In the paper

“Cellular senescence was first formally described approximately five decades ago when Hayflick and colleague (11, 12) showed that normal human cells (in this case fibroblasts) did not proliferate indefinitely in culture.”

What the sources say

• ?Not checked — no full text of the sourcecites [11] source
• ?Not checked — no full text of the sourcecites [12] source

In the paper

“The mechanism behind the finite replicative life span of normal cells is now understood.”

In the paper

“Telomere dysfunction is one of many potentially oncogenic stimuli that can elicit a senescence response (Figure 1).”

In the paper

“In mice, for example, many cells in the adult animal are telomerase positive.”

In the paper

“Even 50 years ago, it was evident that most cancer cells do not have a finite replicative life span (11).”

What the sources say

• ?Not checked — no full text of the sourcecites [11] source

In the paper

“DNA DSBs, such as those induced by ionizing radiation, topoisomerase inhibitors, and other agents, are especially potent senescence inducers (28–30).”

What the sources say

• ?Not checked — no full text of the sourcecites [28] source
• ?Not checked — no full text of the sourcecites [29] source
• ?Not checked — no full text of the sourcecites [30] source

In the paper

“Thus, telomeres, the DNA-protein structures that cap the ends of linear chromosomes, shorten with each cell division (14).”

What the sources say

• ?Not checked — no full text of the sourcecites [14] source

In the paper

“The SASP has powerful paracrine activities, the nature of which suggests that the senescence response is not solely a mechanism for preventing cancer.”